Skip to main content

Tomorrow Investor

IDEX Metals Announces Completion of Option Agreement Transaction with WestGold Metals

IDEX Metals Completes Option Agreement with WestGold | TheNewswire

Vancouver, B.C. – August 18, 2026- TheNewswire – IDEX Metals Corp. (“IDEX” or the “Company”) (TSXV: IDEX; OTCQB: IDXMF) is pleased to announce, its wholly-owned subsidiary, Silver Rock Resources Inc. (the “Optionor”), has completed the previously announced mineral property option agreement (the “Option Agreement”) with WestGold Metals Corp. (“WestGold”), traded on the Canadian Securities Exchange (the “CSE”) under the symbol “WGM.CN”. Pursuant to the Option Agreement, the Optionor granted WestGold an exclusive option to acquire a 90% interest in three of the Company’s exploration properties located in the State of Idaho, USA: the Amie Project, the Silver Rock Project and the Demming Project (collectively, the “Properties”).

This excerpt is quoted from the original release. Read the full announcement on TheNewswire.

Brief Summary

IDEX Metals Corp. has officially completed its mineral property option agreement with WestGold Metals, paving the way for exciting opportunities in exploration projects in Idaho.

  • 90% interest option granted to WestGold in three key projects.
  • The properties are strategically located within Idaho.
  • This agreement enhances IDEX’s portfolio and market reach.

Why it matters: This option agreement not only signifies a significant collaborative effort but also positions both companies for future growth and development within the mining sector.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by TheNewswire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.